Publication

Article

Pharmaceutical Commerce

Pharmaceutical Commerce - September/October 2011
Volume

Hand-carried physicians' samples still predominate, survey finds

Various direct-to-practitioner and ‘alternative’ sample-distribution methods are coming along, but delivery via the rep continues

At the just concluded PDMA Sharing Conference (San Antonio, Sept. 25-29), the PDMA Alliance (www.pdmaaliance.org), event sponsor, together with TGaS Advisors, a consulting firm, presented results of a recent survey of members, who are primarily sample-accountability and PDMA compliance professionals at manufacturers. Respondents are mostly satisfied with their current preferences and capabilities: 74% said that they weren’t planning changes in their processes. But among the remainder, a range of options are being considered: a third are planning to convert to 100% direct-to-practitioner (DTP) methods; 22% are planning the opposite—100% hand-carried delivery (i.e., delivered by reps). The remainder plan a mix of DTP, hand and alternative techniques.

For respondents who are contemplating expanded DTP methods, TGaS captured data that essentially rank these alternatives by popularity. The options being considered are: use of business-reply cards (78%); telesampling (63%—i.e., phone-based offers); e-sampling, making use of physician-frequented websites or online services, will be tried by 44% of respondents, and video detailing (a combination of online video and live telecommunications) will be tried by 22%.

Options are also expanding in how sample or financial-assistance programs are being offered to consumers. 90% of respondents use coupons;76% use vouchers; 24% use a pre-paid card; and 17% offer co-pay assistance.

The full PDMA Alliance/TGaS study is available to Alliance members via the organization’s website.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.